baber/WOPTO huggingface dataset:
Patent NZ-218474-A (NZ)
Title: Disposable diaper with crotch tensioning means to establish outward lateral tension
Inventor: SHIKATA HIROAKI
IPC: A61F13/15
Filed: 1986-12-02
Abstract: A disposable diaper (10) having front and rear waist portions and comprising a liquid permeable topsheet (50); a liquid impermeable backsheet (30) affixed to the topsheet; an absorbent core (40) interposed between the topsheet (50) and the backsheet (30); a crotch portion located intermediate the front and rear waist portions; a pair of side flaps; and crotch tensioning means (60) associated with each of the side flaps. The absorbent core (40) has oppositely disposed end portions and a pair of longitudinally disposed side edges therebetween. The crotch tensioning means (60) further comprises one or more elasticized members extending from an attachment area in the crotch portion of the diaper, across the respective side flap, to a location longitudinally outside of the crotch portion. The crotch tensioning means (60) thereby tend to impose outward lateral tension on the crotch portion of the diaper (10) when in use. The attachment areas for such crotch tensioning means (60) are preferably oppositely disposed within the crotch portion of the diaper (10) and are laterally spaced from one another at a width of less than approximately 153 mm. The resulting disposable diaper (10) provides improved aesthetic fit on the wearer and improved containment of voided materials.
Patent NZ-229636-A (NZ)
Title: A process for the preparation of 2,6-dichlorodiphenylamino-acetic acid derivatives
Inventor: GRAFE INGOMAR
IPC: C07C229/42
Filed: 1989-06-20
Abstract: A novel process for the preparation of 2,6-dichlorodiphenylamine derivatives is described which yields the desired active substance in a technically simple and practicable manner in very good purity and good yield.
Patent NZ-230691-A (NZ)
Title: A pharmaceutical composition comprising a synergistic combination of a plasminogen activator and hirudin
Inventor: HEIM JUTTA
IPC: C12N9/72
Filed: 1989-09-19
Abstract: There is provided a pharmaceutical composition comprising as component A a plasminogen activator and as component B hirudin together with a pharmaceutically acceptable carrier. The pharmaceutical composition can be used for the prophylaxis and therapy of thrombosis or diseases caused by thrombosis.
Patent NZ-232809-A (NZ)
Title: Pharmaceutical compositions comprising therapeutically effective amounts of a cycloserine and d-alanine
Inventor: CORDI ALEXIS A
IPC: A61K31/198
Filed: 1990-03-06
Abstract: A composition is described for use in memory and learning enhancement or for treatment of a cognitive disorder or a psychotic disorder. This composition contains the compound D-cycloserine and D-alanine and provides reduced adverse side effects typically associated with chronic D-cycloserine use.
Patent NZ-241760-A (NZ)
Title: Sequentially stretching zero strain laminate web to increase elastic extensibility in the direction of stretching without damaging the laminate web
Inventor: WEBER GERALD MARTIN
IPC: B29C59/04
Filed: 1992-02-27
Abstract: An improved method and apparatus for incrementally stretching "zero strain" stretch laminate webs to impart elasticity thereto in the direction of stretching, at least up to the point of initial stretching. The "zero strain" stretch laminate material is formed of at least two plies of material which are either intermittently or substantially continuously secured to one another along at least a portion of their coextensive surfaces while in a substantially untensioned ("zero strain") condition. One of the plies is stretchable and elastomeric, while the second ply is elongatable, but not necessarily elastomeric. The second ply will, upon stretching of the laminate, be at least to a degree permanently elongated so that, upon release of the applied tensile forces, it will not return to its original undistorted configuration. This results in z-direction bulking of the laminate web when the applied tension is released as well as subsequent elastic extensibility in the direction of initial stretching, at least up to the point of initial stretching. In a particularly preferred embodiment of the present invention, the mechanical stretching operation is carried out by passing said laminate web between multiple pairs of meshing corrugated rolls, each pair of rolls exhibiting a greater degree of meshing than the preceding pair, to sequentially stretch said web in stages. Sequentially stretching the web in the foregoing manner minimizes damage to the web.
Patent NZ-246182-A (NZ)
Title: Inhibiting alkali-aggregate or alkali-silica reactions in concrete by introducing a substance capable of migrating within the concrete in the presence of an electric field
Inventor: PAGE CHRISTOPHER LYNDON
IPC: E04B1/64
Filed: 1992-12-17
Abstract: PCT No. PCT/GB92/02345 Sec. 371 Date Sep. 8, 1994 Sec. 102(e) Date Sep. 8, 1994 PCT Filed Dec. 17, 1992 PCT Pub. No. WO93/12052 PCT Pub. Date Jun. 24, 1993This invention relates to a method of inhibiting alkali-silica or alkali-aggregate reactions (AAR/ASR) in concrete structures by introducing lithium compounds or the like in conjunction with conventional techniques for the treatment of steel reinforcement corrosion. It is also proposed to provide lithium compounds in repair concretes, grouts or mortars and use the difference in concentration between the article under repair and the repair material to introduce the lithium ions into the concrete under repair, once again inhibiting AAR/ASR reactions.
Patent NZ-260490-A (NZ)
Title: Mono- and bi-pyridyl methyl pyridone derivatives, preparation and pharmaceutical compositions thereof
Inventor: FEY PETER
IPC: C07D401/14
Filed: 1994-05-10
Abstract: Substituted mono- and bipyridylmethylpyridones are prepared either by reaction of pyridones with mono- or bipyridylmethylhalogen compounds or by reaction of pyridone-substituted halopyridines with tetrazolylphenylboronic acids. The substituted mono- and bipyridylmethylpyridones can be employed as active compounds in medicaments, in particular for the treatment of arterial hypertension and atherosclerosis.
Patent NZ-263002-A (NZ)
Title: Crystalline ceftiofur {namely: 7-[2-(2-amino-1,3-thiazol-4-yl)- 2-methoxyimino)acetamido]-3-[(fur-2-ylcarbonyl)thiomethyl]- 3-cephem-4-carboxylic acid} in free acid form
Inventor: DUNN MICHAEL J
IPC: A61K31/545
Filed: 1994-03-07
Abstract: PCT No. PCT/US94/01862 Sec. 371 Date Sep. 11, 1995 Sec. 102(e) Date Sep. 11, 1995 PCT Filed Mar. 7, 1994 PCT Pub. No. WO94/20505 PCT Pub. Date Sep. 15, 1994Anhydrous and crystalline free acid form of the cephalosporin antiobiotic ceftiofur, processes for its manufacture, and pharmaceutical composition containing it are provided.   <IMAGE>
Patent NZ-265353-A (NZ)
Title: Plant treatment sustenance composition; comprises an aminopurine or a derivative or salt thereof and a water soluble compound containing a sulphonyl group
Inventor: CARSTAIRS MARGARET LOUISE
IPC: A01N3/02
Filed: 1994-04-29
Abstract: PCT No. PCT/GB94/00924 Sec. 371 Date Jan. 11, 1996 Sec. 102(e) Date Jan. 11, 1996 PCT Filed Apr. 29, 1994 PCT Pub. No. WO94/24856 PCT Pub. Date Nov. 10, 1994The invention provides a composition for sustaining plant material comprising an aminopurine or a derivative or salt thereof and at least one water soluble sulfonated polyester or sulfonamide.
Patent NZ-296014-A (NZ)
Title: Hot fillable plastics container comprises vacuum panels between ribbed post walls and ribbed lands above and below
Inventor: KRISHNAKUMAR SUPPAYAN M
IPC: B65D1/02
Filed: 1995-10-27
Abstract: A panel design for a hot-fillable plastic container has a tall and slender panel section. The panel configuration provides increased resistance to longitudinal bending and hoop failure, yet provides good hoop flexibility to maximize vacuum panel movement. The panel section has a substantially cylindrical circumference with a plurality of vacuum panels symmetrically disposed about the panel circumference, post walls between the vacuum panels, and land areas above and below the vacuum panels. The ratio of vacuum panel height D to panel diameter C is on the order of 0.85 to 1.05. Longitudinal post ribs are provided in the post walls. The land areas above and below the vacuum panels are of a height E greater than on the order of 0.45 inch, and the ratio of the land area height E to panel diameter C is on the order of greater than 0.1. Circumferential hoop ribs are provided in the land areas to prevent ovalization and hoop collapse.
Patent NZ-301159-A (NZ)
Title: A method of oxygenating water and apparatus therefor
Inventor: TAYLOR DARRELL L
IPC: C02F1/74
Filed: 1996-01-24
Abstract: A process for enriching water with oxygen, wherein water is conducted through a water inlet into a sealed enriching space and through one or more turbulent mixers in the enriching space, oxygen is introduced through an oxygen inlet into the water in the enriching space before passing through the turbulent mixer, and the oxygen-enriched water is recovered. The invention further includes an aerobic process by carrying out a chemical or microbiological reaction in the oxygen-enriched water as the reaction medium, and a therapeutic process of carrying out a therapeutic treatment of a body with an agent containing the oxygen-enriched liquid as a vehicle. The invention also concerns an apparatus for enriching water with oxygen, having a water inlet, a sealed enriching space containing an oxygen inlet, and one or more turbulent mixers, and an outlet for oxygenated water.
Patent NZ-326754-A (NZ)
Title: The use of 2-amino-4-(4-fluorobenzylamino)-1-ethoxy-carbonylaminobenzene or salts thereof for the prophylaxis and treatment of sequelae of chronic reduced circulation in the brain in particular strokes and for neurodegenerative disorders
Inventor: ROSTOCK ANGELIKA
IPC: A61P25/28
Filed: 1996-10-15
Abstract: The disclosure relates to the use of compound (I) or its pharmaceutically usable salts for the prophylaxis and treatment of sequelae of chronic reduced circulation in the brain, in particular strokes, and for the treatment of neurodegenerative disorders.
Patent NZ-326781-A (NZ)
Title: Pasty milk-based food products having a milk content of 75-92 wt% and a viscosity of at least 3 Pa.s
Inventor: PAHNKE OTTO
IPC: A23P20/20
Filed: 1997-01-20
Abstract: A pasty food based food product having a viscosity of at least 3 Pa.s at 10oC and essentially consists of 75-92 wt% of milk which has a)	a fat content of 12-18 wt%; b)	a sugar content of 5-20 wt%, c)	a starch content of 1.5-2.5 wt% and d)	a gel former content of 0.1-0.5 wt% and the ratio of starch to gel former is between 15:1 to 5:1 relative to the total weight is claimed.
Patent NZ-333159-A (NZ)
Title: 1,3,8-triaza-spiro[4,5]decan-4-on derivatives and process of preparation
Inventor: ADAM GEO
IPC: A61K31/435
Filed: 1998-12-03
Abstract: 1,3,8-triaza-spiro[4,5]decan-4-on derivatives of the formula 1 where: A is a ring system of (a) C5-15 cycloalkyl optionally substituted by lower alkyl, trifluoromethyl, phenyl, C5-7 cycloalkyl, spiro-undecan-alkyl or by 2-norbornyl, or is one of the following groups (b)-(d), (e) dodecahydro-acenaphthylen-lyl (f) bicyclo[6.2.0]dec-9-yl (g) and bicyclononan-9-yl R1 is H, lower alkyl, Hal, lower alkoxy, CF3, lower alkyl-phenyl or C5-7 cycloalkyl; R2 is H, lower alkyl, phenyl or lower alkyl-phenyl; R3 is H, lower alkyl, benzyl, lower alkyl-phenyl, lower alkyl-diphenyl and other cyclic rings R4 us H, lower alkyl or nitrilo; R5 and R6 are H, lower alkyl or taken together and with the carbon atoms to which they are joined form a phenyl ring R7 is H or lower alkyl; The dotted line is an optional bond and n is 1-4 Process for preparation and use for the treatment of diseases related to Orphanin (OFQ) receptor is described.
Patent NZ-337262-A (NZ)
Title: 2-alkyl-19-nor-vitamin D compounds and pharmaceutical compositions thereof
Inventor: DELUCA HECTOR F
IPC: A61P17/06
Filed: 1998-02-11
Abstract: This application provides a class of vitamin D related compounds, namely, the 2-alkyl-19-nor-vitamin D derivatives, as well as a general method for their chemical synthesis. The compounds have formula (I), where Y1 and Y2, which may be the same or different, are each selected from the group consisting of hydrogen and a hydroxy-protecting group, R6 is selected from the group consisting of alkyl, hydroxyalkyl and fluoroalkyl, and where the group R represents any of the typical side chains known for vitamin D type compounds. These 2-substituted compounds are characterized by low intestinal calcium transport activity and high bone calcium mobilization activity resulting in novel therapeutic agents for the treatment of diseases where bone formation is desired, particularly low bone turnover osteoporosis. These compounds also exhibit pronounced activity in arresting the proliferation of undifferentiated cells and inducing their differentiation to the monocyte thus evidencing use as anti-cancer agents and for the treatment of diseases such as psoriasis.
Patent NZ-337404-A (NZ)
Title: Sail divided into segments and interconnected by elastic battens extending between fore-leech and after-leech
Inventor: PALM CARL
IPC: B63H9/069
Filed: 1998-01-27
Abstract: The disclosure relates to an arrangement (1) an arrangement for a sail (2) enabling its form to be varied and comprising battens (4-43) extending between the fore-leech (9) and the after-leech (10). According to the disclosure, the form of the battens (4-43) is so arranged as to vary depending on the wind and the desired form of the sail. This can be done as the sail is divided and built of several with between the segment located as battens effecting connectable devices which are elastic across the connection device's length extension.
Patent NZ-337499-A (NZ)
Title: Tapered convolute leaf spring for truck suspensions
Inventor: WILSON WILLIAM
IPC: F16F1/368
Filed: 1998-06-19
Abstract: A leaf spring (14) includes an eye (16) attached to a vehicle frame member (20). A front cantilever portion of the leaf spring (14) extends from the eye (16) to a predetermined point of the leaf spring (14). A rear cantilever portion extends from the predetermined point to an end portion of the leaf spring (14). The rear portion of the leaf spring (14) includes a reverse arch portion. The front portion has a relatively high spring rate and the rear portion has a relatively low spring rate to provide comfortable riding conditions for the vehicle and roll stability for the suspension system.
Patent NZ-500271-A (NZ)
Title: Discharge valve apparatus with valve falling to close as hydrostatic forces on underside reducing with fall in liquid level
Inventor: FROST DOUGLAS ROBERT DAVID
IPC: E03D1/14
Filed: 1998-04-21
Abstract: Discharge valve apparatus for immersion in and discharge of fluid, usually water, from a cistern (not shown) comprises a housing (2), a valve means or piston (3) in the housing (2) for co-operation with an outlet (4) from the housing (2) to prevent flow of fluid from the housing (2) and being movable to open the outlet (4) for flow of fluid therefrom, a pilot valve (5) which is operable to open a free flow between a chamber (6) of the housing (2) and the outlet (4) and means (7) to provide passage of ambient air to the chamber (6) which consists of annular passage 7 intermediate the length of and externally of pilot valve 5, the arrangement being such that with a passage of air being maintained, hydrostatic forces acting on the underside of the valve reduce in proportion to the fluid level fall so that as the fluid falls to a desired level the weight of the valve (3) exceeds the upwards forces whereby to allow the valve to descend and close the outlet (4).
Patent NZ-502444-A (NZ)
Title: Polypeptides with cellobiohydrolase activity (CBH A and CBH B) from Aspergillus
Inventor: VISSER JACOB
IPC: C12N15/00
Filed: 1998-07-31
Abstract: Two peptide sequences are disclosed which encode two cellobiohydrolase polypeptides (CBHA and CBHB) derived from Aspergillus.  These peptides and their variants are described in addition to DNA encoding the peptides, vectors and host cells.  The peptides can be used to produce or process food, animal feed, wood pulp, paper and textiles.
Patent NZ-503116-A (NZ)
Title: Dual mode of operation fireplaces for operation in vented or unvented mode using catalytic converter in unvented mode
Inventor: LYONS DAVID CHARLES
IPC: F24B1/18
Filed: 2000-02-29
Abstract: A dual operation gas fireplace (30) comprises a fireplace having a combustion chamber box (11) and heat exchanger means (13A, 13B) for directing convection heated air into a room to be heated.  A burner means (17) is mounted in the floor (12) of combustion chamber box (11).  A combustion air plenum (15) is underneath burner means (17) and is for supplying outside air to burner means (17).  Heat exchanger means (13A, 13B) is mounted on top of combustion chamber box (11).  Exhaust opening means (22) in the top of combustion chamber box (11) is for conducting hot burned exhaust gasses from combustion chamber box (11) into heat exchanger means (13A, 13B) for passage to an area outside of the room to be heated.  Diversionary blower means (36) are coupled to heat exchanger (13A, 13B) and is for diverting the hot burned exhaust gasses from combustion chamber box (11) through a catalytic converter (26) directly into the room to be heated for operation in a ventless mode of operation.
Patent NZ-504145-A (NZ)
Title: Use of a register containing a master key and locations to allow software authorization in Web pages
Inventor: BEAN RICHARD
IPC: G06F21/12
Filed: 2000-04-20
Abstract: To control the execution or display of software assets at a customer site 38, the assets having been developed using a developer's software 32, the customer's site includes locations containing the assets, a master key purchased by the customer from the developer that specifies the customer site locations for the assets including the location of the master key, and each asset includes a contents key identifying the location of the master key. At a user computer 44 whether the execution or display of the asset downloaded from the customer's site is authorized by the developer is determined by downloading the asset from the customer's site, finding the location of the master key based on the content key in the asset, downloading the master key from the found location on the customer's site, and comparing the locations contained in the master key to the location of the asset to determine if the asset is accessible by the user computer.
Patent NZ-505786-A (NZ)
Title: Fibre distribution box for long fibres
Inventor: ERIKSEN MARIANNE ETLAR
IPC: D04H1/72
Filed: 1998-12-23
Abstract: A forming box 1 for uniformly distributing fibres on a surface for dry forming of a fibrous tissue (e.g. paper). The box has an open bottom and a forming wire 3 and a vacuum box 5 under it. An inlet allows a stream of air containing suspended airborne fibres into the box and rotating spike rollers 7 covering the entire cross- sectional area of the box lay the fibres down in a uniform thickness.
Patent NZ-506872-A (NZ)
Title: Medium and method for viral propagation and growth
Inventor: HEIMINDINGER PIERRE
IPC: C12N5/071
Filed: 1999-03-15
Abstract: Medium for propagating and multiplying viruses in cultured cells is free of human, animal or recombinant albumin and contains mitogenic potato or cucumber proteins or glycoproteins with molecular weights of 10-200 kD.
Patent NZ-509149-A (NZ)
Title: Adenosine A3 receptor modulators
Inventor: BARALDI PIER GIOVANNI
IPC: C07D487/12
Filed: 1999-09-15
Abstract: A compound of formula (I) or formula (II), wherein; A is imidizole, pyrazole, or triazole, R is -C(X)R1, -C(X)-N(R1)2, -C(X)SR1, -SOnR1, -SOnOR1, -SOnSR1, or SOn-N(R1)2, R1 is hydrogen, optionally substituted alkyl, alkenyl, alkynyl, aryl, heteroaryl, heterocyclic, or alkonoyl, R2 is hydrogen, optionally substituted alkyl, aralkyl, heteroaryl, or aryl, R3 is an optionally substituted heterocyclic group, X is O, S, or NR1, n is 1 or 2, The above compounds are used in the preparation of medicaments for treating disorders responsive to adenosine A3 receptor modulators.
Patent NZ-513422-A (NZ)
Title: G-CSF analogues that do not possess any hematopoietic activity and are useful as antagonists against G-CSF effect, such as overproduction of G-CSF
Inventor: OSSLUND TIMOTHY D
IPC: G06F19/00
Filed: 1994-01-25
Abstract: A G-CSF hybrid molecule comprising a G-CSF moiety and a protein moiety, wherein: (a) The G-CSF moiety comprises: (i) A G-CSF internal core of helices A, B, C and D as set forth in Fig 4, the internal core helices comprising corresponding amino acid residues as set forth in Seq ID No. 2; (ii) An external loop between helices A and B comprising corresponding amino acid residues as set forth in Seq ID No. 2; (iii) An external loop between helices B and C comprising corresponding amino acid residues as set forth in Seq ID No. 2; (iv) An external loop between helices D and A; and (v)  An N-terminus and a C-terminus, the N-terminus being connected to helix D and the C-terminus being connected to helix C, the N-terminus and the C-terminus each comprising a portion of amino acids 120-146 of Seq ID No. 2; (b) The protein moiety is connected to an amino acid of subpart (v).
Patent NZ-516158-A (NZ)
Title: Heated volatile dispenser
Inventor: SOLLER DOUGLAS A
IPC: A61L9/03
Filed: 2000-06-16
Abstract: A heated volatile dispenser and a volatile carrier for use therewith are disclosed. The volatile dispenser has a closed heating chamber having ceiling and exit vents. A fuel burner is contained within the heating chamber, and a carrier holder is positioned over the fuel burner. The carrier holder holds a volatile carrier in a location above the fuel burner such that hot gases from the fuel burner pass the carrier holder and directly heat a volatile carrier held thereby. The volatile carrier may be held in an edge-on orientation with respect to the flow of hot gases, or transversely with respect to them. The volatile carrier has an inward end that has a cross-sectional profile made to be complementary to that of an insert slot through which the volatile carrier must be inserted for use. An alternative embodiment is shown that uses a candle as a fuel burner. A kit is shown that includes a candle and a volatile carrier that are designed to be exhausted at the same time so that the candle's consumption serves as a use-cue for the volatile carrier. Methods of dispensing volatiles are disclosed.
Patent NZ-516860-A (NZ)
Title: A gaming machine with improved display means
Inventor: FONG COLIN
IPC: G07F17/34
Filed: 2000-10-11
Abstract: A gaming machine has a display including a plurality of discrete display positions at each of which at least one symbol is to be displayed and a control means. The control means controls operation of the display of symbols in the display positions of the display. The display positions are arranged in a matrix having m rows and n columns, where m is greater than 1 and m does not equal n to provide for m length award lines and n length award lines. A symbol occurring at one display position in the matrix is independent of, and unassociated with, the occurrence of symbols at any other display position in the matrix. At least certain of the award lines are in the form of paylines where the occurrence of predetermined combinations of symbols on any such payline awards a prize. When predetermined combinations of symbols occur on other different award lines a trigger condition for a particular feature is formed.